Cellular Therapy
CellExSys and Itochu partnership announced
Published in Hepatitis Weekly, November 18th, 2002
Under the terms of the letter of agreement, CellExSys and Itochu plan to form a Japanese joint venture company that will be responsible for the development, sales, marketing, and manufacturing of CellExSys' potential cell therapy products in Japan.
David M. Schubert, CellExSys, said, "We believe that CellExSys' cell therapy technology has significant potential and we plan to begin clinical trials in hepatitis B as early as 2003 in the United States with additional...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2002-11-18)
More Articles from Hepatitis Weekly
- Hemophilia
Combination therapy effective for hemophiliacs with chronic hepatitis C - Hepatitis C Virus Therapy
Higher doses of ribavirin increase risk for anemia in chronic hepatitis C - Blood Transfusion
Unsuspected and unreported infection may be cause of Japanese liver cancers - Hepatitis C Complications
Patients with myocarditis, hepatitis C virus, respond to immunosuppression - Hepatitis C Virus Detection
Assay for hepatitis C core antigen suggests storage degrades viral components - Appointments
Drug discovery company names new chief financial officer - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
